Oral Administration of Bombyx mori Silk Fibroin Nanoparticles Modulates the Gut Microbiota in Healthy Mice
Macromolecular Bioscience · 2026-03 · 26 (3)
DOI: 10.1002/mabi.202500517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 13.03.2026. Verfasst von Suting Zhong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Bioresource Research, College of Animal Science, Zhejiang University, Hangzhou, Zhejiang, P. R. China. Hauptthemen laut MEDLINE: Fibroins, Nanoparticles, Gastrointestinal Microbiome, Bombyx. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Key R&D Program of China, Zhejiang Provincial Science and Technology Plan, State of Sericulture Industry Technology System.
Abstract (Originalsprache)
Silk fibroin nanoparticles (SFNPs) have shown great promise as oral drug delivery carriers due to their favorable biocompatibility and tunable release properties. However, their effects on the gut microbiota under physiological conditions remain poorly understood. Herein, we systematically investigated the impact of orally administered SFNPs on the composition and temporal dynamics of the gut microbiome in healthy mice. SFNPs were thoroughly characterized, showing stability in intestinal fluid and structural transition to β‐sheet conformation. Our results revealed that SFNP administration induced significant, dose‐dependent shifts in microbial communities, notably increasing the Firmicutes / Bacteroidota ratio and enriching potentially beneficial genera such as Faecalibaculum and Dubosiella , while reducing taxa associated with inflammation and metabolic disorders. Medium doses (2.4 and 12 mg/kg) promoted sustained potentially beneficial effects, whereas a high dose (60 mg/kg) led to transient dysbiosis and enrichment of the inflammation‐related genus Enterorhabdus . These findings underscore the dose‐responsive modulatory effects of SFNPs on gut microbiota and highlight the importance of microecological safety in the design of nanocarrier systems for oral administration. This study provides critical insights into the gut‐nanoparticle interface and supports the potential of SFNPs in microbiome‐based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Applied Bioresource Research, College of Animal Science, Zhejiang University, Hangzhou, Zhejiang, P. R. China.
- The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, P. R. China.
- Zhejiang Provincial Key Laboratory of Silk and Silk Protein New Materials, Hangzhou, Zhejiang, P. R. China.
ORCID-Profile: Mingying Yang
Förderung
- National Key R&D Program of China
- Zhejiang Provincial Science and Technology Plan
- State of Sericulture Industry Technology System
- National Key Research and Development Program of China
Zitieren
APA
Zhong, S., Zhao, X., Cheng, Q., Cheng, L., Yang, M., Zhang, M., Wan, Q., Wang, J., Xu, Z., Shuai, Y., & Yang, M. (2026). Oral Administration of Bombyx mori Silk Fibroin Nanoparticles Modulates the Gut Microbiota in Healthy Mice. Macromolecular Bioscience, 26(3). https://doi.org/10.1002/mabi.202500517
Vancouver
Zhong S, Zhao X, Cheng Q, Cheng L, Yang M, Zhang M, et al. Oral Administration of Bombyx mori Silk Fibroin Nanoparticles Modulates the Gut Microbiota in Healthy Mice. Macromolecular Bioscience. 2026;26(3). doi:10.1002/mabi.202500517
BibTeX
@article{Zhong2026,
author = {Zhong, Suting and Zhao, Xin and Cheng, Qichao and Cheng, Lixia and Yang, Mei and Zhang, Meng and Wan, Quan and Wang, Jie and Xu, Zongpu and Shuai, Yajun and Yang, Mingying},
title = {Oral Administration of Bombyx mori Silk Fibroin Nanoparticles Modulates the Gut Microbiota in Healthy Mice},
journal = {Macromolecular Bioscience},
year = {2026},
volume = {26},
number = {3},
doi = {10.1002/mabi.202500517}
}
EUVIMED